111, Inc. Sponsored ADR (NASDAQ:YI) Sees Significant Growth in Short Interest

111, Inc. Sponsored ADR (NASDAQ:YI) saw a large increase in short interest during the month of October. As of October 30th, there was short interest totaling 13,122 shares, an increase of 204.2% from the October 15th total of 4,313 shares. Based on an average trading volume of 18,014 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.3% of the shares of the company are short sold.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, November 2nd. One analyst has rated the stock with a Sell rating. According to MarketBeat, the company has a consensus rating of “Sell”.

111 Stock Down 0.4%

Shares of NASDAQ:YI traded down $0.01 during midday trading on Friday, hitting $2.84. 4,258 shares of the stock traded hands, compared to its average volume of 17,801. 111 has a one year low of $2.48 and a one year high of $11.17. The stock has a market capitalization of $24.96 million, a PE ratio of -1.77 and a beta of 0.78. The business’s 50 day moving average is $3.22 and its two-hundred day moving average is $4.93.

111 (NASDAQ:YI) last posted its earnings results on Friday, September 18th. The company reported ($0.60) earnings per share for the quarter. The business had revenue of $338.55 million during the quarter.

About 111

111, Inc. is a China-based digital healthcare company that connects pharmaceutical manufacturers, distributors, pharmacies, healthcare providers and consumers through online platforms and technology-enabled services. The company operates a pharmaceutical business-to-business platform that supplies medicines and healthcare products to pharmacies and other customers. It also offers online pharmacy services and digital tools intended to support purchasing, inventory management and other pharmacy operations.